Nika Pharmaceuticals, Inc (NIKA) Liabilities and Shareholders Equity (2021 - 2023)
Nika Pharmaceuticals' (NIKA) quarterly Liabilities and Shareholders Equity came in at $864.0 in Q4 2023, little changed YoY from $864.0 in Q4 2022, and down 92.08% on a QoQ basis from $10910.0 in Q3 2023.
Nika Pharmaceuticals, Inc (NIKA) Liabilities and Shareholders Equity (2021 - 2023) Analysis & Trends
Nika Pharmaceuticals (NIKA) has 3 years of Liabilities and Shareholders Equity data on file, last reported at $864.0 in Q4 2023.
- Quarterly Liabilities and Shareholders Equity changed 0.0% year-over-year to $864.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $27286.0 (up 103.54% YoY) and the FY2023 annual result came in at $864.0, changed 0.0% from the prior year.
- Liabilities and Shareholders Equity declined to $864.0 in Q4 2023, from $10910.0 in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $11053.0 in Q2 2023 to a low of $83.0 in Q1 2022.
- A 3-year average of $4565.7 and a median of $3914.0 in 2022 frame the typical range for Liabilities and Shareholders Equity.
- The widest YoY moves for Liabilities and Shareholders Equity: up 5272.29% in 2023, down 0.0% in 2023.
- Tracing NIKA's Liabilities and Shareholders Equity over 3 years: stood at $399.0 in 2021, then surged by 116.54% to $864.0 in 2022, then changed by 0.0% to $864.0 in 2023.
- The last three Liabilities and Shareholders Equity figures came in at $864.0 (Q4 2023), $10910.0 (Q3 2023), and $11053.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 864.00 |
| Sep 30, 2023 | 10,910.00 |
| Jun 30, 2023 | 11,053.00 |
| Mar 31, 2023 | 4,459.00 |
| Dec 31, 2022 | 864.00 |
| Sep 30, 2022 | 3,914.00 |
| Jun 30, 2022 | 8,545.00 |
| Mar 31, 2022 | 83.00 |
| Dec 31, 2021 | 399.00 |